Mumbai: Shares of Sun Pharmaceutical Industries fell sharply on Thursday after the US drug regulator flagged one of the ...

Shares of Sun Pharmaceutical Industries Ltd. are trading 2.4% lower on Thursday, December 18, after the US Food and Drug ...

Shares of Sun Pharmaceutical Industries closed 2.77% lower on Thursday (December 18, 2025) at ₹1,745.35 apiece on the BSE ...

Sun Pharma's Baska plant in Gujarat receives OAI status from the US FDA after inspection, adding near-term regulatory uncertainty but not impacting current US supplies ...

We continue to manufacture and supply approved products from the facility to the US market. We will work with the regulator ...

Sun Pharmaceutical Industries declined 2.68% to Rs 1746.95 after the company announced that the US FDA, post an audit, has determined the Baska facility inspection classification as Official Action ...

Indian equity indices open lower amid global uncertainty; discover key market movers and trends to watch today.

Mumbai: Sun Pharma has announced that the company has received Official Action Indicated (OAI) status from the U.S. Food and ...

The court, however, permitted Sun Pharma to manufacture and export semaglutide to non-patent countries, extending the same relief it granted Dr. Reddy’s Laboratories in a similar dispute earlier this ...

Sun Pharmaceutical Industries Limited ( ($IN:SUNPHARMA) ) has provided an update. Sun Pharmaceutical Industries Limited announced that the US FDA ...

Indian-made medicines have reached in over 200 markets and has a strong presence in regions where regulatory oversight ...

According to an exchange filing, the pharma major said the inspection took place between September 8 and September 19, 2025, ...